GlassScriptPhysician profile
Hsiang L Chen
NPI 1528038908
$3,208.05
in general payments reported to CMS, 2019-2025
22 companies · $757 in 2025
The $757 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $827 · 2020: $376 · 2021: $82.64 · 2022: $312 · 2023: $284 · 2024: $569 · 2025: $757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155 · Education: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,154.75 |
| Education | $455.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $932.58 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $850.40 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $266.28 | 2024-2025 | Gemtesa, Myfembree |
| Millicent US INC | $194.34 | 2019-2025 | Intrarosa |
| Amag Pharmaceuticals, INC. | $153.95 | 2019 | |
| Ascend Therapeutics US, LLC | $142.95 | 2021-2023 | |
| Allergan, INC. | $86.89 | 2019-2020 | |
| Avion Pharmaceuticals | $83.29 | 2019-2020 | |
| Exeltis, USA INC. | $75.98 | 2019-2020 | |
| Pfizer INC. | $64.92 | 2024 | |
| Scynexis, INC. | $53.49 | 2022 | |
| Therapeuticsmd, INC. | $50.34 | 2019-2020 | |
| Aspira Women'S Health INC | $38.37 | 2022 | |
| Duchesnay USA Incorporated | $35.24 | 2019 | |
| Vertical Pharmaceuticals, LLC | $32.99 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $30.27 | 2024 | Injectafer |
| Mayne Pharma Commercial LLC | $29.17 | 2022 | |
| Hologic Sales and Service, LLC | $20.23 | 2025 | Thinprep 2000 Processor, Aptima |
| Celularity INC. | $18.00 | 2019 | |
| Coopersurgical, INC. | $17.10 | 2020 | |
| Renovia INC | $17.09 | 2019 | |
| Mimedx Group, INC. | $14.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hsiang Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.